" /> Human Adenovirus Type 5 Encoding HPV-16 E6/E7 Vaccine IBRX-042 - CISMeF





Preferred Label : Human Adenovirus Type 5 Encoding HPV-16 E6/E7 Vaccine IBRX-042;

NCIt synonyms : hAd5-encoding HPV16 E6/E7 Vaccine IBRX-042; hAd5 Encoding HPV16 E6/E7 Vaccine IBRX-042; hAd5-HPV E6.ETSD-IRES-E7.ETSD Vaccine IBRX-042;

NCIt definition : A cancer vaccine composed of an adenovirus type 5 (Ad5) vector that encodes for the viral oncoproteins E6 and E7 derived from human papillomavirus serotype 16 (HPV-16; HPV16), with potential immunomodulating and antineoplastic activities. Upon administration, hAd5 encoding HPV-16 E6/E7 vaccine IBRX-042 induces expression of the HPV-16 E6/E7 proteins, which stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL)-mediated response against tumor cells expressing HPV-16 E6 and E7. Oncoproteins E6 and E7 play a key role in the development of various malignancies.;

Molecule name : IBRX 042; IBRX-042;

Details


You can consult :


Nous contacter.
13/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.